3 completed, 1 active not recruiting, 1 enrolling by invitation, 1 terminated. 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 3, Active not recruiting 1, Enrolling by invitation 1, Terminated 1, Withdrawn 1 |
Follow abaloparatide: new trials by email Literature Review of abaloparatide trials Research Report on abaloparatide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Osteoporotic Medications on Vertebral Bone Quality Score Abaloparatide - Lumbar Degenerative Disease | Phase 2 | Enrolling by invitation | State University of New York at Buffalo | 60 | 2026-06-18 | 2026-07-23 |
| PTH Analog Type II Odontoid Fracture Abaloparatide, Hard collar immobilization - Odontoid Fracture | Phase 2 | Terminated | David Lunardini | 22 | 2022-05-18 | 2024-09-19 |
| Effect of Abaloparatide on Lumbar Disc Degeneration Abaloparatide, Placebo - Degeneration Disc Intervertebral | Phase 2 | Withdrawn | Johns Hopkins University | 2021-03-01 | 2021-04-12 | |
| Abaloparatide and Pelvic Fracture Healing Abaloparatide 80 micrograms per Pen dose, Placebo prefilled injector pen - Fracture of Pelvis (Disorder) | Phase 2 | Completed | Hospital for Special Surgery, New York | 48 | 2020-09-17 | 2024-06-14 |
| Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery Abaloparatide, Placebo - Spinal Fusion | Phase 2 | Active not recruiting | Hospital for Special Surgery, New York | 96 | 2019-08-14 | 2026-09-28 |
| Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With Osteoporosis Abaloparatide Transdermal (50 mcg), Abaloparatide Transdermal (100 mcg), Abaloparatide Transdermal (150 mcg) - Post Menopausal Osteoporosis | Phase 2 | Completed | Radius Health, Inc. | 250 | 2012-09-25 | 2020-06-16 |
| Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis teriparatide, Placebo, BA058 20 µg - Osteoporosis | Phase 2 | Completed | Radius Health, Inc. | 222 | 2007-04-01 | 2017-10-30 |
Osteoporosis (3) · Bone Diseases, Metabolic (1) · Fractures, Bone (1) · Hip Fractures (1) · Intervertebral Disc Degeneration (1) · Low Back Pain (1) · Osteoporosis, Postmenopausal (1) · Pain (1)
Hospital for Special Surgery, New York (2) · Radius Health, Inc. (2) · David Lunardini (1) · Johns Hopkins University (1) · State University of New York at Buffalo (1)
United States (7) · Denmark (1) · Estonia (1) · Poland (1)
David Lunardini, MD (1) · Emily Stein, MD (1) · Janet Crane, M.D. (1) · Jeri W Nieves, PhD (1) · Joseph Lane, MD (1)